Clinical effectiveness of eprosartan and hydroxyzine in patients with mild to moderate arterial hypertension and coexisting anxiety

QR Code

Clinical effectiveness of eprosartan and hydroxyzine in patients with mild to moderate arterial hypertension and coexisting anxiety

Aim. То evaluate clinical effectiveness of eprosartan and hydroxyzine in patients with mild to moderate arterial hypertension (AH) and coexisting anxiety.Material and methods. The study included 34 patients (8 men, 26 women) aged 36—76 years (mean age 56,7+11,1 years) with Stage I-II AH. Stage I AH...

Full description

Saved in:

Bibliographic Details
Main Authors:	G. V. Pogosova, E. E. Koltunov, E. Yu. Spivak, Yu. S. Belova, A. V. Karpova
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2009-02-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	arterial hypertension therapy hydroxyzine eprosartan
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1132
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Angiotensin receptor-1 antagonist eprosartan in patients with mild to moderate arterial hypertension
by: A. V. Shabalin, et al.
Published: (2005-12-01)

Eprosartan effects on intravascular platelet activity in patients with arterial hypertension and metabolic syndrome
by: I. N. Medvedev, et al.
Published: (2008-02-01)

THE EFFECTIVENESS OF CARVEDILOL AND EPROSARTAN IN PATIENTS WITH METABOLIC SYNDROME AND CHRONIC HEART FAILURE
by: R. L. Dashnamirov
Published: (2014-04-01)

Оrganoprotective efficiency of eprosartan in patients with chronic glomerulonephritis
by: Ye. V. Kalyuzhina, et al.
Published: (2007-03-01)

EFFECT OF THE SEDATIVE COMPONENT OF PREMEDICATION, ACHIEVED BY USING HYDROXYZINE HYDROCHLORIDE ON PSYCHOVEGETATIVE AND HORMONAL STATUS IN THOSE SUFFERING FROM THYROID DISORDERS
by: K. A. Badikova, et al.
Published: (2017-12-01)

The influence of long-time eprosartan therapy on left ventricle geometriy and function in patients with arterial hypertension and diastolic dysfunction
by: E. V. Osipov, et al.
Published: (2010-03-01)

Anti-remodeling efficacy of eprosartan in patients with essential hypertension, and gene polymorphism of angiotensin II type 1 receptors
by: B. Sh. Karimova, et al.
Published: (2005-02-01)

Pharmacogenetic aspects of eprosartan therapy and polymorphic markers of renin-angiotensin-aldosterone system genes in Uzbek patients with essential arterial hypertension
by: D. R. Kurbanova, et al.
Published: (2009-06-01)

Inhibition of Tick-Borne Encephalitis Virus Replication with Eprosartan and Ribavirin In Vitro and In Vivo
by: G. N. Leonova, et al.
Published: (2020-12-01)

Developing approaches to treating arterial hypertension in regard to possible pathways of angiotensin II synthesis
by: N. M. Chikhladze, et al.
Published: (2006-04-01)

Comparison of platelet hemostasis effects for angiotensin receptor blockers in patients with arterial hypertension and metabolic syndrome
by: I. N. Medvedev, et al.
Published: (2007-08-01)

Arterial hypertension with stroke risk: clinical features, circadian blood pressure profiles, angiotensin II antagonist treatment
by: V. B. Simonenko, et al.
Published: (2005-06-01)

Еprosartan therapy effectiveness in arterial hypertension patients after stroke or transient ischemic attack
by: Yu. M. Pozdnyakov, et al.
Published: (2006-12-01)

CLINICAL EFFICACY AND SAFETY OF AND A-2 ANTAGONIST EPROSARTAN IN PATIENTS WITH MILD AND MODERATE HYPERTENSION. RESULTS OF A MULTICENTER TRIAL
by: L. I. Olbinskaya, et al.
Published: (2001-06-01)

CLINICAL AND PHARMACOKINETIC EQUIVALENCE OF ORIGINAL AND GENERIC AMLODIPINE IN PATIENTS WITH MILD-TO-MODERATE ARTERIAL HYPERTENSION
by: N. A. Belolipetskiy, et al.
Published: (2015-12-01)

Antihypertensive spirapril effectiveness in patients with mild to moderate arterial hypertension
by: M. M. Beraya, et al.
Published: (1970-01-01)

EFFICACY AND SAFETY OF ALBAREL IN PATIENTS WITH MILD, MODERATE AND SEVERE HYPERTENSION
by: N. N. Borovkov, et al.
Published: (2003-08-01)

Spirapril effects on heart remodeling in patients with mild to moderate arterial hypertension
by: M. M. Beraya, et al.
Published: (2007-02-01)

Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome
by: S. S. Yakushin, et al.
Published: (2004-12-01)

ZOFENOPRIL PLUS HYDROCHLOROTHIAZIDE COMBINATION THERAPY FOR THE TREATMENT OF MILD TO MODERATE HYPERTENSION
by: A. Zanchetti, et al.
Published: (2011-10-01)

ANXIETY DISORDERS IN CARDIOLOGY PRACTICE: CURRENT EVIDENCE ON THE PROBLEM
by: N. V. Pogosova, et al.
Published: (2010-10-01)

New, long-acting form of nifedipine: efficacy and safety in patients with mild to moderate arterial hypertension
by: E. V. Alimova, et al.
Published: (2004-08-01)

THE EVALUATION OF ANTIHYPERTENSIVE EFFICACY OF ORALLY-DISPERSING FORM OF PERINDOPRIL IN PATIENTS WITH MILD TO MODERATE ARTERIAL HYPERTENSION
by: R. A. Khokhlov, et al.
Published: (2014-12-01)

CHOICE OF THE INITIAL TREATMENT FOR MILD TO MODERATE ARTERIAL HYPERTENSION IN MOSCOW PRIMARY PRACTICE
by: S. V. Gatsura, et al.
Published: (2015-09-01)

EFFECTIVENESS AND SAFETY OF TWO COMBINATION ANTIHYPERTENSIVE THERAPY VARIANTS IN PATIENTS WITH MILD TO MODERATE ARTERIAL HYPERTENSION
by: S. V. Cheremushkin, et al.
Published: (2011-06-01)

CLINICAL EFFICACY OF COMBINATION THERAPY WITH PERINDOPRIL AND INDAPAMIDE IN PATIENTS WITH MILD AND MODERATE ARTERIAL HYPERTENSION
by: G. J. Abdullayeva, et al.
Published: (2016-03-01)

Effectiveness, safety, cognitive and emotional effects of amplodipine antihypertensive therapy in women with mild to moderate arterial hypertension
by: T. S. Polyatykina, et al.
Published: (2006-10-01)

Metoprolol retard antihypertensive effectiveness in patients with mild to moderate arterial hypertension (multi-center study "Prolonger" results)
by: Yu. N. Sirenko, et al.
Published: (2006-04-01)

Bisoprolol medications in a comparative study on effectiveness and tolerability of original agent and its generic in patients with mild to moderate arterial hypertension
by: S. Yu. Martsevich, et al.
Published: (2007-12-01)

Perindopril and hydrochlorthiazide effects on endothelium-dependent vasodilatation and angiotensin-converting enzyme activity in patients with mild to moderate arterial hypertension
by: T. V. Aparina, et al.
Published: (2005-06-01)

Determination of neurometabolism in patients with mild and moderate cognitive impairments
by: N. N. Mikheev, et al.
Published: (2016-02-01)

Effects of Allisartan on Uric Acid, Left Atrial, Left Ventricular, and Artery Stiffness in Mild‐to‐Moderate Essential Hypertension
by: Yancui Sun, et al.
Published: (2025-06-01)

ANTIHYPERTENSIVE EFFICACY AND SAFETY OF OLMESARTAN MEDOXOMIL AND RAMIPRIL IN ELDERLY PATIENTS WITH MILD TO MODERATE ESSENTIAL HYPERTENSION: THE ESPORT STUDY
by: E. Malacco, et al.
Published: (2012-02-01)

CLINICAL EFFICACY AND PECULIARITY OF COMPLIANCE WITH 48-WEEK LONG THERAPY WITH EGILOK RETARD IN PATIENTS WITH MILD TO MODERATE HYPERTENSION
by: V. E. Oleynikov, et al.
Published: (2016-01-01)

ANTIHYPERTENSIVE EFFICACY AND SAFETY OF OLMESARTAN AND RAMIPRILIN ELDERLY PATIENTS WITH MILD TO MODERATE SYSTOLIC AND DIASTOLICESSENTIAL HYPERTENSION
by: J‑M. Mallion, et al.
Published: (2012-06-01)

Socio-cognitive processes in mild-moderate depression
by: Prathima Alevoor Raghavendra, et al.
Published: (2025-07-01)

Optimization of approaches to the treatment of mild to moderate ulcerative colitis
by: S. S. Belous, et al.
Published: (2021-09-01)

COMPARATIVE STUDY OF COMBINED DRUGS OF ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE: «RENIPRIL HT» AND «CO-RENITEC» IN PATIENTS WITH MILD TO MODERATE ARTERIAL HYPERTENSION
by: S. Y. Martsevich, et al.
Published: (2015-12-01)

Arterial hypertension and coronary heart disease treatment compliance – a key factor in cardiovascular mortality reduction
by: G. V. Pogosova, et al.
Published: (2007-02-01)

EFFICACY AND TOLERABILITY OF LERCANIDIPINE IN ELDERLY PATIENTS WITH MILD TO MODERATE HYPERTENSION IN A PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY
by: M. A. Ninci, et al.
Published: (2016-01-01)